SCHEMBL6510959

SCHEMBL6510959

Cc1nc(N=C(N)Nc2cccc(Oc3ccccc3)c2)nc2ccccc12

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.74
RECQL P46063 2/20 0.74
NPC1 O15118 1/20 0.74
CYP3A4 P08684 1/20 0.74
CYP2C19 P33261 1/20 0.74
STAT3 P40763 1/20 0.74
HIF1A Q16665 1/20 0.74
MAPK1 P28482 2/20 0.55
RAD52 P43351 2/20 0.54
MPO P05164 1/20 0.54
SMN1; SMN2 Q16637 3/20 0.53
RAB9A P51151 1/20 0.53
MAPT P10636 4/20 0.53
LMNA P02545 3/20 0.53
ALDH1A1 P00352 2/20 0.53
HTT P42858 1/20 0.53
KMT2A Q03164 3/20 0.50
GAA P10253 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
BACE1 P56817 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6517381 0.80 SMN1; SMN2 (0.53) CYP1A2RECQLNPC1CYP3A4CYP2C19
SCHEMBL6509984 0.77 MAPK1 (0.54) CYP1A2NPC1MAPK1RAD52SMN1; SMN2
SCHEMBL6509097 0.75 MAPK1 (0.54) CYP1A2MAPK1RAD52SMN1; SMN2RAB9A
SCHEMBL5923406 0.75 MEN1 (0.48) NPC1MAPK1SMN1; SMN2RAB9AMAPT
SCHEMBL6512853 0.74 SIGMAR1 (0.72) CYP1A2MAPK1SMN1; SMN2RAB9AMAPT
SCHEMBL29531432 0.72 MPO (1.00) CYP1A2RECQLNPC1CYP3A4CYP2C19
Hydrochloric Acid SCHEMBL29767736 0.71 MPO (0.97) CYP1A2RECQLNPC1CYP3A4CYP2C19
SCHEMBL6510712 0.71 CRHBP (0.60) CYP1A2RECQLNPC1CYP3A4CYP2C19
SCHEMBL6512924 0.70 CRHBP (0.68) CYP1A2MAPK1SMN1; SMN2RAB9AMAPT
SCHEMBL10498926 0.70 CRHBP (0.83) CYP1A2RECQLNPC1CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005095345-A2 HETEROARYL GUANIDINES AS INHIBITORS OF VIRAL REPLICATION ACHILLION PHARMACEUTICALS, INC. (US) 2005-10-13 WO claimed